Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Part of our biomarkers week, here we explain genomics research in Manchester, and how it's improving care for women at high risk of breast cancer.
Continue reading full article: Manchester BRC Biomarkers week – Genomics
Manchester is a leading centre for biomarker development, brought together by the NIHR Manchester BRC’s biomarkers ‘cross-cutting’ research theme. Part of our biomarkers week, here we explain biostatistics and how they're improving care and treatments.
Continue reading full article: Manchester BRC Biomarkers week – Biostatistics
Manchester is a leading centre for biomarker development, brought together by the NIHR Manchester BRC’s biomarkers ‘cross-cutting’ research theme. Part of our biomarkers week, we explain their importance to health and research.
Continue reading full article: Manchester BRC Biomarkers week – What is a biomarker and why are they important?
Four research projects within our musculoskeletal theme have been awarded a share of £20,000 to ‘pump-prime’ their work.
Continue reading full article: Four musculoskeletal projects awarded funding to ‘pump-prime’ research
In 2020, researchers within our adult and childhood arthritis programmes will be featured in every issue of Arthritis Digest , opening with Professor Wendy Thomson, our Programme Lead forInflammatory Arthritis in Children.
Continue reading full article: Focus on childhood arthritis – Professor Wendy Thomson speaks to Arthritis Digest
In the third blog in our ‘addressing health inequalities in research’ series, our Data Management Lead, Gareth Adaway, discusses the role data plays in our work.
Continue reading full article: How we are using data to address health inequalities in research
Part of our regular Rapid Translational Incubator events and webinars, this webinar will provide an overview of sponsorship processes at the University of Manchester.
Continue reading full article: Webinar – Sponsorship advice for trials and studies – 28.04.2020
Manchester BRC researchers have launched a trial on a bedside genetic test that will predict whether newborn babies receiving antibiotics in intensive care are at risk of irreversible hearing loss.
Continue reading full article: Manchester BRC’s emergency genetic test could prevent antibiotic – related hearing loss in newborns